Inventor · disambiguated record
Evan Hecker
Also filed as: HECKER EVAN · HECKER EVAN A
8 granted patents·4 pending applications·70 citations·filing 2003–2024
83Inventor score
Files withSPERO THERAPEUTICS INC4SCHERING CORP2CUBIST PHARM INC1HARVARD COLLEGE1KARYOPHARM THERAPEUTICS INC1
Top patents by PatentIndex Score
12 records- 0194US7132445B23,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsPHARMACOPEIA DRUG DISCOVERY·Filed 2003·Granted Nov 7, 2006·58 cites·82 claims
- 0286US9688644B2Synthesis of Tetracyclines and intermediates theretoHARVARD COLLEGE·Filed 2015·Granted Jun 27, 2017·3 cites·21 claims
- 0385US9073829B2Synthesis of tetracyclines and intermediates theretoMYERS ANDREW G·Filed 2010·Granted Jul 7, 2015·5 cites·20 claims
- 0483US2025051334A1Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of useSPERO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0582US12098155B2Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of useSPERO THERAPEUTICS INC·Filed 2023·Granted Sep 24, 2024·0 cites·16 claims
- 0679US10889587B2Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of useSPERO THERAPEUTICS INC·Filed 2018·Granted Jan 12, 2021·1 cites·16 claims
- 0778US7691856B2Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligandsSCHERING CORP·Filed 2007·Granted Apr 6, 2010·3 cites·67 claims
- 0872US11718621B2Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of useSPERO THERAPEUTICS INC·Filed 2020·Granted Aug 8, 2023·0 cites·16 claims
- 0958US2024287041A1Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline formsKARYOPHARM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1056US9120796B2B-lactamase inhibitor picoline saltCUBIST PHARM INC·Filed 2014·Granted Sep 1, 2015·0 cites·22 claims
- 1153US2011213029A13,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor LigandsSCHERING CORP·Filed 2011·Application pending·0 cites
- 1249US2004186142A1Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine receptor ligandsSCHERING CORP PHARMACOPEIA INC·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Evan Hecker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →